Literature DB >> 7684470

Release of human immunodeficiency virus by THP-1 cells and human macrophages is regulated by cellular adherence and activation.

R J Shattock1, J S Friedland, G E Griffin.   

Abstract

Macrophage adherence, an important regulatory signal, has the potential to affect human immunodeficiency virus (HIV) production either directly or by priming monocytes to respond to other activating signals. We have investigated the role of adherence as an activator of HIV-1 transcription and release. The effects of adherence on HIV-1 transcription were examined by using THP-1 cells, a human monocytic cell line, transfected with HIV long terminal repeat (LTR)-chloramphenicol acetyltransferase (CAT) constructs. The effects of adherence on release of HIV-1 were investigated in both HIV-1-infected THP-1 cells and human peripheral blood monocyte-derived macrophages (MDM). Adherence of lipopolysaccharide (LPS)-stimulated THP-1 cells to either tissue culture plastic or endothelial cells was crucial for enhanced HIV-1 transcription as measured by LTR-CAT expression. Such increased LTR-CAT expression did not occur with an HIV LTR construct containing mutated NF-kappa B binding sites. In contrast, release of whole HIV, measured by reverse transcriptase (RT) activity in tissue culture medium, was reduced upon adherence of stimulated HIV-1-infected THP-1 cells without suppression of HIV LTR-CAT transcription or p24 release. This finding suggested that activation of adherent monocytic cells interfered with HIV assembly and release. Although the reduction of RT activity following activation of HIV-1-infected MDM was independent of adhesion, adherence alone of nonstimulated HIV-infected MDM to endothelial cells was sufficient to induce a reduction in RT release. This study demonstrates that LPS stimulation of monocytic cells enhances HIV LTR transcription under adherent conditions. In contrast, activation of adherent monocytic cells infected with HIV reduced viral release.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7684470      PMCID: PMC237704     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  26 in total

1.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

2.  Human monocyte inflammatory mediator gene expression is selectively regulated by adherence substrates.

Authors:  D F Eierman; C E Johnson; J S Haskill
Journal:  J Immunol       Date:  1989-03-15       Impact factor: 5.422

3.  Construction of recombinant murine retroviruses that express the human T-cell leukemia virus type II and human T-cell lymphotropic virus type III trans activator genes.

Authors:  C A Rosen; J G Sodroski; K Campbell; W A Haseltine
Journal:  J Virol       Date:  1986-01       Impact factor: 5.103

4.  The role of mononuclear phagocytes in HTLV-III/LAV infection.

Authors:  S Gartner; P Markovits; D M Markovitz; M H Kaplan; R C Gallo; M Popovic
Journal:  Science       Date:  1986-07-11       Impact factor: 47.728

Review 5.  The macrophage in the persistence and pathogenesis of HIV infection.

Authors:  H E Gendelman; J M Orenstein; L M Baca; B Weiser; H Burger; D C Kalter; M S Meltzer
Journal:  AIDS       Date:  1989-08       Impact factor: 4.177

6.  Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells.

Authors:  C M Gorman; L F Moffat; B H Howard
Journal:  Mol Cell Biol       Date:  1982-09       Impact factor: 4.272

7.  Adherence induces selective mRNA expression of monocyte mediators and proto-oncogenes.

Authors:  S Haskill; C Johnson; D Eierman; S Becker; K Warren
Journal:  J Immunol       Date:  1988-03-01       Impact factor: 5.422

8.  Activation of HIV gene expression during monocyte differentiation by induction of NF-kappa B.

Authors:  G E Griffin; K Leung; T M Folks; S Kunkel; G J Nabel
Journal:  Nature       Date:  1989-05-04       Impact factor: 49.962

9.  Interferons and bacterial lipopolysaccharide protect macrophages from productive infection by human immunodeficiency virus in vitro.

Authors:  R S Kornbluth; P S Oh; J R Munis; P H Cleveland; D D Richman
Journal:  J Exp Med       Date:  1989-03-01       Impact factor: 14.307

10.  Interferon gamma induces the expression of human immunodeficiency virus in persistently infected promonocytic cells (U1) and redirects the production of virions to intracytoplasmic vacuoles in phorbol myristate acetate-differentiated U1 cells.

Authors:  P Biswas; G Poli; A L Kinter; J S Justement; S K Stanley; W J Maury; P Bressler; J M Orenstein; A S Fauci
Journal:  J Exp Med       Date:  1992-09-01       Impact factor: 14.307

View more
  5 in total

1.  Endothelial cells enhance human immunodeficiency virus type 1 replication in macrophages through a C/EBP-dependent mechanism.

Authors:  E S Lee; H Zhou; A J Henderson
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

2.  Human immunodeficiency virus type 1 induction mediated by genistein is linked to cell cycle arrest in G2.

Authors:  J Gozlan; J L Lathey; S A Spector
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

3.  Effect of a modulator deletion on transcription of the human cytomegalovirus major immediate-early genes in infected undifferentiated and differentiated cells.

Authors:  J L Meier; M F Stinski
Journal:  J Virol       Date:  1997-02       Impact factor: 5.103

4.  Equine infectious anemia virus replication is upregulated during differentiation of blood monocytes from acutely infected horses.

Authors:  D C Sellon; K M Walker; K E Russell; S T Perry; P Covington; F J Fuller
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

5.  Ligand-engaged urokinase-type plasminogen activator receptor and activation of the CD11b/CD18 integrin inhibit late events of HIV expression in monocytic cells.

Authors:  Massimo Alfano; Samanta A Mariani; Chiara Elia; Ruggero Pardi; Francesco Blasi; Guido Poli
Journal:  Blood       Date:  2008-10-21       Impact factor: 22.113

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.